Biogen Inc at Evercore ISI HealthCONx Conference Transcript
Okay. Excellent. Well, thank you guys for being here. Pleasure to have Biogen management join us. We're only going to talk about the 10,000 patients by end of March and no other topic. But in all seriousness, thank you, Priya, for being here. I'll turn it over to you to kick things off.
Sure. So delighted to be here. I think we believe we've had a really good year and met all the business priorities that we set out -- Chris set out at the outset of the year. So it was about the launches, the approvals, the R&D prioritization, recruiting a new head of research, and really focusing attention on the new wave of products that we believe we have the ability and capability to bring to patients with high unmet need. And I think that on all of these priorities, we feel we've made significant progress and we are entering 2024 really with a lot of promise and a lot of things to look
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
